DC Field | Value | Language |
---|---|---|
dc.contributor.author | S Hong | - |
dc.contributor.author | D W Choi | - |
dc.contributor.author | H N Kim | - |
dc.contributor.author | C G Park | - |
dc.contributor.author | Wonhwa Lee | - |
dc.contributor.author | H H Park | - |
dc.date.accessioned | 2022-04-29T06:10:50Z | - |
dc.date.available | 2022-04-29T06:10:50Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/25847 | - |
dc.description.abstract | Nanoparticles have been extensively used as carriers for the delivery of chemicals and biomolecular drugs, such as anticancer drugs and therapeutic proteins. Natural biomolecules, such as proteins, are an attractive alternative to synthetic polymers commonly used in nanoparticle formulation because of their safety. In general, protein nanoparticles offer many advantages, such as biocompatibility and biodegradability. Moreover, the preparation of protein nanoparticles and the corresponding encapsulation process involved mild conditions without the use of toxic chemicals or organic solvents. Protein nanoparticles can be generated using proteins, such as fibroins, albumin, gelatin, gliadine, legumin, 30Kc19, lipoprotein, and ferritin proteins, and are prepared through emulsion, electrospray, and desolvation methods. This review introduces the proteins used and methods used in generating protein nanoparticles and compares the corresponding advantages and disadvantages of each. | - |
dc.publisher | MDPI | - |
dc.title | Protein-based nanoparticles as drug delivery systems | - |
dc.title.alternative | Protein-based nanoparticles as drug delivery systems | - |
dc.type | Article | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.number | 7 | - |
dc.citation.endPage | 604 | - |
dc.citation.startPage | 604 | - |
dc.citation.volume | 12 | - |
dc.contributor.affiliatedAuthor | Wonhwa Lee | - |
dc.contributor.alternativeName | 홍세영 | - |
dc.contributor.alternativeName | 최동욱 | - |
dc.contributor.alternativeName | 김홍남 | - |
dc.contributor.alternativeName | 박춘권 | - |
dc.contributor.alternativeName | 이원화 | - |
dc.contributor.alternativeName | 박희호 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, vol. 12, no. 7, pp. 604-604 | - |
dc.identifier.doi | 10.3390/pharmaceutics12070604 | - |
dc.subject.keyword | protein nanoparticle | - |
dc.subject.keyword | drug delivery | - |
dc.subject.keyword | biocompatible | - |
dc.subject.keyword | biodegradable | - |
dc.subject.keyword | controlled release | - |
dc.subject.local | protein nanoparticle | - |
dc.subject.local | Drug delivery | - |
dc.subject.local | drug delivery | - |
dc.subject.local | Biocompatible | - |
dc.subject.local | biocompatible | - |
dc.subject.local | biodegradable | - |
dc.subject.local | controlled release | - |
dc.subject.local | Controlled release | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.